Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.75.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.75.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CH.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CH.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.570NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.570NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.570NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.633NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.633NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.633NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DD.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DD.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DD.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.136NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.136NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.136NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XAYNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XAYNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAYNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DJ.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DJ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DJ.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XAENUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XAENYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAENChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.467NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.467NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.467NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.484NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.484NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.484NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.476NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.476NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.476NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.19NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.19NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.18NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.18NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.18NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.404NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-18259.5US
B.1.1.404NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.404NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-15848China
CV.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CV.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CV.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DJ.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DJ.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DJ.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used